Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by TechOneon Jun 22, 2022 2:21pm
335 Views
Post# 34774762

Spectral 2022 AGM

Spectral 2022 AGMWell, there is some thing different at Spectrall for sure.. 1st time I have received an e-mail from the company..   Here it is.. 

Afternoon,

Thank you for attending Spectral’s 2022 AGM.  Due to a technical issue, those virtually attending via the “Guest” login as opposed to the  “Registered Holder” login were unable to submit questions during the Q&A session.  We want to ensure shareholders have the opportunity to ask questions and so we are reaching out directly to you to confirm if you have any questions following our AGM?

Please advise and we will take efforts to address

Regards


Blair McInnis – Chief Financial Officer

Spectral Medical Inc.

135 The West Mall, Unit 2 | Toronto, ON | M9C 1C2

T: 416.626.3233 x 2100 | bmcinnis@spectraldx.com

<< Previous
Bullboard Posts
Next >>